In view of the high incidence of BRCA2 6174delT carrier state in some populations (e.g., Ashkenazi Jews, ~0.9%), it will also be important to examine if children from families carrying the heterozygous BRCA2 6174delT mutation have higher incidence of medulloblastoma than non-carriers. The gene discussed is BRCA2; the disease is medulloblastoma.